Descrizione

Risk of bias assessment across included randomized controlled trials evaluating probiotic interventions for irritable bowel syndrome is summarized.

Figure 2

Chart

Source Paper

Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.

Nutrients (2023)

PMID: 37686889

DOI: 10.3390/nu15173856

Cite This Figure

![Figure 2: Risk of bias assessment across included randomized controlled trials evaluating probiotic interventions for irritable bowel syndrome is summarized.]()

> Source: Peiwei Xie et al. "Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritab." *Nutrients*, 2023. PMID: [37686889](https://pubmed.ncbi.nlm.nih.gov/37686889/)

<figure>
  <img src="" alt="Risk of bias assessment across included randomized controlled trials evaluating probiotic interventions for irritable bowel syndrome is summarized." />
  <figcaption>Figure 2. Risk of bias assessment across included randomized controlled trials evaluating probiotic interventions for irritable bowel syndrome is summarized.<br>  Source: Peiwei Xie et al. "Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritab." <em>Nutrients</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37686889/">37686889</a></figcaption>
</figure>

Evidenze correlate

Bacillus coagulans per Irritable Bowel Syndrome (IBS)

Grado B · 3 studi

Lactobacillus acidophilus per Irritable Bowel Syndrome (IBS)

Grado B · 3 studi